Monday, September 21, 2020
                                                                    12:00 p.m. to 1:00 p.m.
                                                                                   Zoom

                    https://zoom.us/j/2336818578?pwd=YXBkTGxQdnNweHY1WmdEYXYwY3A3UT09

                                                                        Password: pathology

                “An Overview of Correctional Health Care Case Law and Presentation of the Texas Model”
                                                                              presented by

   Lannette C. Linthicum, MD, CCHP-A, FACP, Director, Health Services Division, Texas Department of Criminal                                                                            Justice, Huntsville, TX

                         Objectives: At the conclusion of this presentation, participants should be able to:

• Examine ethics principles and relate those principles to the correctional health care setting

   • Review key correctional health care case law

                          • Describe the Texas state correctional managed health care model

Methodology: Lecture followed by question and answer session

Disclosure Statement (Speaker):  Dr. Linthicum has no relevant financial relationships with commercial interests to disclose.

Disclosure Statement (Planning Committee Members):  Drs. Anthony O. Okorodudu, Judith F. Aronson, Heather Stevenson-Lerner and Mrs. Brenda Johnson have no relevant financial relationships with commercial interests to disclose.

Accreditation Statement: The University of Texas Medical Branch at Galveston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement: The University of Texas Medical Branch at Galveston designates this live activity for a maximum of 39 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ETHICS:  UTMB designates this educational activity for up to 1 hour in ethics/professional responsibility.

Translational Research Seminar Series presented by W. Sam Fagg, MS, PhD

"Pluripotent stem cells as tools for regenerative medicine and models of development"

Tuesday, September 22, 2020

4:00pm

Join Microsoft Teams Meeting

+1 409-240-0721 United States, Galveston (Toll)

Conference ID: 761 544 000#

TRCC (Texas Regional CTSA Consortium) Quantitative Seminar Series

“Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score Approach”

Luohua Jiang, Ph.D.

Associate Professor- Department of Epidemiology University of California, Irvine

Tuesday, August 25, 2020 Noon – 1 pm Virtual (Zoom)

This seminar contributes to achieving one or more of the CTSA core competencies in the category of Statistical Approaches.

Abstract: Many community-based translations of evidence-based interventions are designed as one-arm studies due to ethical and other considerations. Evaluating the impacts of such programs is challenging. Here we examine the effectiveness of the lifestyle intervention implemented by the Special Diabetes Program for Indians Diabetes Prevention (SDPI-DP) demonstration project, a translational lifestyle intervention among American Indian and Alaska Native communities. Data from the landmark Diabetes Prevention Program placebo group was used as a historical control. We compared the use of propensity score (PS) and disease risk score (DRS) matching to adjust for potential confounder imbalance between groups. The unadjusted hazard ratio (HR) for diabetes risk was 0.35 for SDPI-DP lifestyle intervention vs. control. However, when relevant diabetes risk factors were considered, the adjusted HR estimates were attenuated toward 1. The differences in estimated HRs using the PS and DRS approaches were relatively small but DRS matching resulted in more participants being matched and smaller standard errors of effect estimates. Carefully employed, publicly available randomized clinical trial data can be used as a historical control to evaluate the intervention effectiveness of one-arm community translational initiatives. It is critical to use a proper statistical method to balance the distributions of potential confounders between comparison groups in this kind of evaluations.

Participating TRCC Institutions include: UTMB, UTHSC-Houston, UTHSC-San Antonio, and UT Southwestern

For Zoom Meeting information please contact Casey Sendejas.

You are invited to support the Alzheimer’s Foundation by participating in the 2020 Walk to End Alzheimer’s event on October 17. Held annually in more than 600 communities nationwide, the Alzheimer's Association Walk to End Alzheimer’s is the world’s largest fundraiser for Alzheimer’s care, support and research. Although this year’s event won’t be a large in-person gathering, we are still walking — and calling on participants of all ages and abilities to join the fight against the disease. Making safety the top priority, participants will walk in small teams of friends or individually, logging their walk through a phone application. There is no fee to register for the Walk, for additional information visit: https://act.alz.org/site/SPageServer?pagename=walk_homepage.